Emerging trends of BCG immunotherapy for bladder cancer in last decade: a bibliometric and visualization analysis

BACKGROUND: One of the milestones in bacterial-mediated therapy for cancer, Bacillus Calmette-Guerin (BCG) has been used to treat bladder cancer (BC) for more than 30 years. BCG immunotherapy is now the standard of care for high-grade non-muscle invasive bladder cancer (NMIBC) following transurethra...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xingfeng, He, Fang, Zhang, Wenjin, Fu, Yao, Cao, Zhiqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140368/
https://www.ncbi.nlm.nih.gov/pubmed/37124495
http://dx.doi.org/10.3389/fonc.2023.1092969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140368/
https://www.ncbi.nlm.nih.gov/pubmed/37124495
http://dx.doi.org/10.3389/fonc.2023.1092969

Ejemplares similares